![](/img/cover-not-exists.png)
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
Basso, M, Strippoli, A, Orlandi, A, Martini, M, Calegari, M A, Schinzari, G, Di Salvatore, M, Cenci, T, Cassano, A, Larocca, L M, Barone, CVolume:
108
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.526
Date:
January, 2013
File:
PDF, 217 KB
english, 2013